Cantitate/Preț
Produs

Insulin Resistance and Cancer: Epidemiology, Cellular and Molecular Mechanisms and Clinical Implications (Energy Balance and Cancer, nr. 1)

Editat de I. George Fantus
Notă GoodReads:
en Limba Engleză Carte Paperback – 19 Apr 2013
This book reviews the epidemiological associations between insulin resistance and cancer. This is followed by reviews of animal models which support this relationship and provide insight into potential mechanisms. Several chapters then provide detailed examination of the cellular and molecular changes characterizing the insulin resistant state, such as hyperinsulinemia, abnormal metabolism and hormone signaling, and how these interact with various tumor characteristics. For example some tumors present increased quantities of the fetal form of the insulin receptor, unique regulation of oxidative (Krebs’ cycle) metabolism (Warburg effect), as well as mutations in various relevant signaling pathways. Finally, the clinical implications of these data are integrated with considerations of insulin “sensitization” and potential metabolic interventions to prevent and treat cancer. It should be noted that while a number of cancers are associated with obesity the authors here have focused primarily on breast cancer as a key and significant model.
Citește tot Restrânge
Toate formatele și edițiile
Toate formatele și edițiile Preț Express
Carte Paperback (1) 85958 lei  Economic 5-7 săpt. +36303 lei  12-20 zile
  Springer – 19 Apr 2013 85958 lei  Economic 5-7 săpt. +36303 lei  12-20 zile
Carte Hardback (1) 92919 lei  Economic 5-7 săpt. +38249 lei  6-13 zile
  Springer – 19 Aug 2011 92919 lei  Economic 5-7 săpt. +38249 lei  6-13 zile

Din seria Energy Balance and Cancer

Preț: 85958 lei

Preț vechi: 90483 lei
-5%

Puncte Express: 1289

Preț estimativ în valută:
17198 19118$ 14877£

Carte tipărită la comandă

Livrare economică 28 noiembrie-12 decembrie
Livrare express 05-13 noiembrie pentru 37302 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781461428183
ISBN-10: 1461428181
Pagini: 312
Dimensiuni: 155 x 235 x 16 mm
Greutate: 0.48 kg
Ediția: 2011
Editura: Springer
Colecția Springer
Seria Energy Balance and Cancer

Locul publicării: New York, NY, United States

Public țintă

Research

Cuprins

Insulin and the Physiology of Carbohydrate and Lipid Metabolism.
2. Insulin Signalling: Cellular and Molecular Mechanisms
3. Mechanisms of Insulin Resistance, Obesity and Metabolic Syndrome
4. Obesity and Cancer: Epidemiology
5. Insulin, Insulin Resistance and Cancer Associations
6. Animal Models of Hyperinsulinemia, Insulin Resistance and Cancer
7. Actions of Insulin as a Survival and Growth Factor: Akt/PKB, mTOR and MAPK Signaling.
8. Potential Mechanisms Linking Insulin to Cancer
9. Insulin-like Growth Factors and Cancer
10. Insulin, IGF Receptors and Cancer
11. Clinical Implications for Cancer Treatment and Prevention

Textul de pe ultima copertă

This book reviews the epidemiological associations between insulin resistance and cancer. This is followed by reviews of animal models which support this relationship and provide insight into potential mechanisms. Several chapters then provide detailed examination of the cellular and molecular changes characterizing the insulin resistant state, such as hyperinsulinemia, abnormal metabolism and hormone signaling, and how these interact with various tumor characteristics. For example some tumors present increased quantities of the fetal form of the insulin receptor, unique regulation of oxidative (Krebs’ cycle) metabolism (Warburg effect), as well as mutations in various relevant signaling pathways. Finally, the clinical implications of these data are integrated with considerations of insulin “sensitization” and potential metabolic interventions to prevent and treat cancer. It should be noted that while a number of cancers are associated with obesity the authors here have focused primarily on breast cancer as a key and significant model.

Caracteristici

In-depth detail of basic concepts of insulin and cancer and how they interact.
Reviews the epidemiological associations between insulin resistance and cancer.
Focuses primarily on breast cancer as a key and significant model for cancer research and insulin.